Cosmos Health Sees 2027 Revenue $155.80M Vs $59.5M In 2024; 2027 Adjusted EBITDA $29.40M Vs -$1.21M In 2024
Portfolio Pulse from Benzinga Newsdesk
Cosmos Health projects significant growth with 2027 revenue expected to reach $155.80 million, up from $59.5 million in 2024. The company also anticipates a positive adjusted EBITDA of $29.40 million in 2027, compared to a negative $1.21 million in 2024.
September 18, 2024 | 5:38 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cosmos Health is projecting a substantial increase in revenue and a turnaround in adjusted EBITDA by 2027, indicating strong future growth prospects.
The significant increase in projected revenue and the shift from negative to positive adjusted EBITDA suggest strong growth and improved financial health for Cosmos Health. This positive outlook is likely to boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100